Aveeno Baby Partners With Over 11,000 Indian Healthcare Professionals To Pledge To ‘Start Early, Stop Atopic Dermatitis

* Sets GUINNESS WORLD RECORDS™ Title

* Breaks GUINNESS WORLD RECORDS title for ‘Most pledges for dermatological disease awareness campaign in one week’

* 82% of Indian parents are unaware of Atopic Dermatitis, reveals Aveeno Baby survey

* Know more about Aveeno ‘Start Early, Stop Atopic Dermatitis’ campaign: https://www.youtube.com/shorts/kl5SYwYzIcY

In a pioneering initiative, Aveeno Baby, US#1 Paediatrician Recommended brand a product range for baby’s sensitive, skin broke a GUINNESS WORLD RECORDS title for ‘Most pledges for dermatological disease awareness campaign in one week’ by joining hands with 11201 Indian paediatricians, dermatologists and healthcare professionals to pledge to prevent Atopic Dermatitis (AD) by early usage of moisturizers on newborns.

Atopic dermatitis (AD) is one of the most common forms of eczema, a chronic inflammatory skin condition that results in dry, itchy skin, with a dysfunctional skin barrier. Early intervention is crucial for the management of AD in children.  Sensitive skin conditions like AD-prone skin in babies are becoming increasingly common in India, necessitating a deeper understanding of this condition.

With aim to create awareness about sensitive skin conditions like Atopic Dermatitis, Aveeno Baby has launched ‘Start Early, Stop Atopic Dermatitis’ campaign to highlight the importance of power of oats-based moisturizers to better manage AD skin conditions.

Approximately 60% of children with atopic dermatitis develop symptoms within the first year of life, and 90% show signs by the age of five. The most common symptoms observed in babies include redness, itching, dry skin, and rash. Often, sensitive skin conditions in babies goes undiagnosed, leading to prolonged skin discomfort. The unpredictable flare-ups not only affect the baby’s skin but also disrupt their sleep cycle, impacting the well-being of the entire family. A survey conducted by Aveeno Baby and Firstcry revealed, that nearly 82% of Indian parents are unaware of Atopic Dermatitis, underscoring the need to raise awareness to manage such skin conditions effectively.

Mr. Manoj Gadgil, Business Unit, Essential Health and Skin Health, and Vice President Marketing, Kenvue said, “Sensitive skin calls for special care. Today, there is significant lack of awareness about sensitive skin conditions in babies and necessary therapeutic measures to manage it. We aim to educate and provide parents with an expert/paediatrician recommended product to reduce the incidence and severity of AD in infants. By collaborating with India’s leading healthcare professionals across the country, we aim to strengthen awareness on the role of oats-based moisturizers to manage mild to extreme sensitive skin conditions like atopic dermatitis in babies. We are delighted with the overwhelming response we have received from healthcare practitioners to set the Guinness World Record.

This initiative will play an instrumental role in strengthening awareness and highlighting the powerful role that Aveeno Baby can also play in managing sensitive skin conditions.”

According to Dr. Sumitra N, MBBS, DCH, Bangalore, “We are seeing a lot of sensitive skin conditions in babies owing to change in weather conditions especially in metropolitan cities like Bangalore. The fluctuations between warm and cooler temperatures can leave a baby’s delicate skin more vulnerable and prone dryness and related skin conditions. I would like to compliment Aveeno Baby for its efforts to raise awareness about sensitive skin conditions like Atopic Dermatitis and the role of moisturizers in preventing these conditions. A proactive approach can significantly reduce the risk of atopic dermatitis and other skin disorders in babies.”

To raise awareness about sensitive skin and AD amongst healthcare community and parents, Kenvue showcased its latest science on colloidal oatmeal as a powerful solution to address dry and sensitive skin in babies at PEDICON 2024, the 61st National Conference of Indian Academy of Paediatrics (IAP), an annual scientific conclave conducted by Indian Academy of Pediatrics (IAP) earlier this year.

As part of its ‘Start Early, Stop AD’ campaign, Aveeno baby will continue its awareness efforts through knowledge sessions with leading paediatricians, dermatologists, experts across cities coupled with influencer campaigns to share knowledge on early intervention and the use of moisturizers to manage sensitive skin conditions in their babies.

About Aveeno Baby®

Aveeno® Baby is the US#1* paediatrician recommended brand made with the power of oat for baby’s sensitive skin’. The history of Aveeno® Baby is built upon our commitment to combine scientific research with the ingredients found in nature. Our scientists unlock the power of a selection of natural ingredients – science and nature, working together, in harmony.  We bring nourishing solutions to your skincare so even the most sensitive skin feels soothed and moisturized.

At Aveeno® we partner with healthcare professionals and leading experts – dermatologists, pediatricians, pharmacists and scientists. We are the US#1 Pediatrician Recommended brand and a natural choice for your baby’s sensitive skin. For further information, visit Aveeno® India.

About Kenvue:

Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, Johnson’s®, Listerine®, Neutrogena®, and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.